Prof. Kui Liu | Breast Cancer | Best Researcher Award

Posted on 22/01/202522/01/2025 by Pencis

Prof. Kui Liu | Breast Cancer | Best Researcher Award

Zibo Central Hospital | China

AUTHOR PROFILE

Scopus

KUI LIU, Ph.D. – PROFESSIONAL PROFILE

🎓 EARLY ACADEMIC PURSUITS

Kui Liu embarked on a robust academic journey in clinical and diagnostic sciences:

2002-2005: Completed a degree in Clinical Laboratory Medicine from Linyi Medical College, China.
2012-2015: Pursued a master’s degree in Clinical Laboratory Diagnostics at Jiangsu University, Zhenjiang, China.
2016-2020: Earned a Ph.D. in Immunology from Southeast University, Nanjing, China, contributing significantly to the field with innovative research in immune responses and diagnostics.

💼 PROFESSIONAL ENDEAVORS

Kui Liu has accumulated extensive clinical and technical experience over nearly two decades:

2020-Present: Associate Chief Technician at the Center of Translational Medicine, Zibo Central Hospital, where he plays a key role in integrating research with clinical applications.
2015-2016: Worked as a Docimaster at the Blood Bank of the First Hospital of Zibo, focusing on blood storage and safety protocols.
2008-2012: Served as a Docimaster at the same institution, ensuring high-quality diagnostic practices.
2005-2008: Began his career as a Docimaster in the Laboratory Department, excelling in clinical diagnostics.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST CANCER

Kui Liu’s research is centered on advancing the fields of immunology and clinical diagnostics, with a focus on:

The study of immune responses in various pathological conditions.
Development of innovative diagnostic tools and techniques.
Translation of scientific research into clinical solutions.

His work on immune mechanisms and diagnostic technologies has led to groundbreaking advancements in translational medicine.

💡 FUNDING AND RESEARCH IMPACT

Kui Liu has been a driving force behind several high-impact research projects, securing prestigious grants to fund cutting-edge studies:

Grant no. 81602330: Principal Investigator for the National Natural Science Foundation of China (2017-2019), focusing on immunological research.
Grant no. 81972002: Co-Investigator for the National Natural Science Foundation of China (2019-2022), contributing to collaborative advancements in the field.
Grant no. J18KA299: Co-Investigator in the Shandong Province Higher Educational Science and Technology Program (2019-2021).
Grant no. ZR2015PH056: Co-Investigator for the Natural Science Foundation of Shandong Province (2015-2016).
Grant no. CXLX13_689: Principal Investigator for the Innovation Project of Cultivating Graduates of Jiangsu Province (2013-2015).

🌍 IMPACT AND INFLUENCE

Innovator in Translational Medicine: Kui Liu has bridged the gap between laboratory research and clinical application, enhancing diagnostic capabilities in immunology.
National and Regional Contributions: Through leadership in provincial and national projects, he has elevated the standards of diagnostic medicine across China.
Collaboration and Mentorship: Actively fosters collaborations and guides aspiring researchers, contributing to the growth of the next generation of medical scientists.

📚 ACADEMIC CITES AND RECOGNITION

Kui Liu has received widespread recognition for his contributions, reflected in numerous citations and acknowledgments in scientific journals. His findings have influenced medical practices and inspired continued exploration in immunology.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Kui Liu’s career is a testament to his commitment to advancing medical science. His future endeavors include:

Leading innovative studies in immunological diagnostics.
Expanding the applications of translational medicine.
Continuing to inspire young researchers through mentorship and collaboration.

🌟CONCLUSION

Dr. Kui Liu’s remarkable journey from foundational clinical studies to advanced immunological research exemplifies a career dedicated to innovation, excellence, and impact. His contributions to translational medicine and diagnostics have not only advanced scientific understanding but also improved clinical practices, particularly in immunology.

📊🔬NOTABLE PUBLICATION:

1. Title: LncRNA DANCR-miR-758-3p-PAX6 Molecular Network Regulates Apoptosis and Autophagy of Breast Cancer Cells
  - Authors: Zhang, X.H., Li, B.F., Ding, J., Ma, F.X., Wu, X.Y.
  - Journal: Cancer Management and Research
  - Year: 2020
1. Title: LncRNA PVT1 Regulates Gallbladder Cancer Progression through miR-30d-5p
  - Authors: Liu, K., Xu, Q.
  - Journal: Journal of Biological Regulators and Homeostatic Agents
  - Year: 2020
1. Title: TIPE1 Inhibits Osteosarcoma Tumorigenesis and Progression by Regulating PRMT1 Mediated STAT3 Arginine Methylation
  - Authors: Yang, M., Zhang, Y., Liu, G., Liu, Q., Zhao, P.
  - Journal: Cell Death and Disease
  - Year: 2022
1. Title: CircRNA hsa_circ_0008500 Acts as a miR-1301-3p Sponge to Promote Osteoblast Mineralization by Upregulating PADI4
  - Authors: Zhai, Q., Zhao, Y., Wang, L., Li, T., Wang, L.
  - Journal: Frontiers in Cell and Developmental Biology
  - Year: 2020
1. Title: miR-369-3p Inhibits Tumorigenesis of Hepatocellular Carcinoma by Binding to PAX6
  - Authors: Xu, Q., Liu, K.
  - Journal: Journal of Biological Regulators and Homeostatic Agents
  - Year: 2020

Dr. Hiu Yee Kwan – Obesity and Cancer – Women Researcher Award

Posted on 12/03/202414/03/2024 by Pencis

Dr. Hiu Yee Kwan - Obesity and Cancer - Women Researcher Award

Hong Kong Baptist University - Hong Kong

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS

Kwan Hiu Yee's academic journey began with a strong foundation in the sciences. She earned a B.Sc. with 2nd Honors Upper Class in Biology and Biotechnology from the Faculty of Science at The University of Hong Kong (1992-1995).

PROFESSIONAL ENDEAVORS

Continuing her academic pursuits, Kwan Hiu Yee completed her Ph.D. at the Department of Physiology, Faculty of Medicine, The Chinese University of Hong Kong (2001-2006). She further honed her expertise by obtaining a Certificate in Epidemiology & Control of Infectious Diseases from the School of Public Health at The Chinese University of Hong Kong in 2005.

CONTRIBUTIONS AND RESEARCH FOCUS ON OBESITY AND CANCER

Kwan Hiu Yee's research focus has been on the intersection of physiology, public health, and Chinese medicine. Her contributions extend to the exploration of vascular ion channel targets in cardiovascular diseases, as evidenced by winning the Second Prize of China Medical Science and Technology Award in 2020.

IMPACT AND INFLUENCE

As an Associate Professor and Associate Director in the Teaching and Research Division at the Centre for Cancer & Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kwan Hiu Yee plays a pivotal role in shaping the academic landscape.

ACADEMIC CITES

Her impactful work is reflected in numerous academic accolades, including the CUHK Young Scholars Dissertation Awards nomination in 2007 and the HKBU School Performance Award in Teaching in 2022.

LEGACY AND FUTURE CONTRIBUTIONS

Kwan Hiu Yee's legacy is marked by her active involvement in professional memberships, such as the International Society for Extracellular Vesicles and the Hong Kong Association for the Study of Obesity and Cancer. With a diverse skill set, including a Master of Arts in Translation & Linguistics, she continues to contribute to academia.

NOTABLE PUBLICATIONS

Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions. 2024

Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis. 2024

Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay. 2023 (3)

Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2. 2022 (6)

Omics approach to reveal the effects of obesity on the protein profiles of the exosomes derived from different adipose depots. 2022

Dr. Fatemeh Kanaani Nejad – Breast Cancer Screening – Best Researcher Award

Posted on 14/02/202415/02/2024 by Pencis

Dr. Fatemeh Kanaani Nejad - Breast Cancer Screening - Best Researcher Award

Anesthesiology and Critical Care Research Center - Iran

Author Profile

Google Scholar

EARLY ACADEMIC PURSUITS:

Fatemeh Kanaani Nejad was an academically driven individual from early on, demonstrating her commitment to education during her high school years at Farzanegan High School in Shiraz, Iran (2011-2014). Her consistent dedication and performance laid the foundation for her subsequent academic journey.

PROFESSIONAL ENDEAVORS:

After completing high school, Fatemeh pursued her Medical Doctor (MD) degree at Isfahan University of Medical Sciences, Isfahan, Iran, from February to July 2015. She continued her medical education at Shiraz University of Medical Sciences, Shiraz, Iran, graduating in February 2022. Following her academic achievements, she embarked on a postdoctoral research position at the Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, starting in September 2022.

CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST CANCER SCREENING

Fatemeh actively engaged in various workshops and certifications, showcasing her commitment to expanding her skill set. Notably, she participated in workshops such as Search, Study Design, and Proposal Writing, as well as Python training. Her research focus, primarily in the field of Anesthesiology and Critical Care, is evident in her contributions to poster presentations for the European Society of Radiology (ECR 2023). These contributions cover topics ranging from targeted ultrasound of the breast to the application of shear wave elastography in breast cancer screening.

IMPACT AND INFLUENCE:

Fatemeh's impact extends beyond her academic pursuits. Her poster presentation on "Anti-Inflammatory Therapy in Hair Loss Treatment" at The Second International Conference on Holly Prophet Mohammad’s Tradition reflects her engagement with interdisciplinary topics and potential implications for medical treatments.

ACADEMIC CITES:

While specific citation numbers are not provided, Fatemeh's work is disseminated through DOI-linked poster presentations. This suggests that her research is accessible and has the potential for citation within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS:

Fatemeh's legacy is marked by her achievements as the first-ranked student in Farzanegan high school and the second-ranked student among Isfahan University of Medical Sciences students in 2015. Her mentorship role in the Medical Physics Research Center and continued contributions to conferences indicate a promising future of further academic and professional accomplishments.